Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Feb. 29, 2020	Feb. 28, 2019
Operating activities:
Net income	$ 484.0	$ 109.0
Reconciliation of net income to net cash provided by operating activities:
Depreciation and amortization	145.3	142.3
Stock-based compensation expense	82.6	59.7
Gain on sale of assets	(372.3)	0.0
Payments for acquisition-related performance compensation	(75.9)	0.0
Net periodic pension and postretirement expense	21.5	0.3
Undistributed earnings of affiliates, net	0.2	0.0
Pension and postretirement contributions	(8.2)	(0.5)
Deferred income taxes	15.1	(23.4)
Change in assets and liabilities:
Accounts receivable, net	(89.8)	(155.7)
Other current assets	(41.0)	(51.5)
Accounts payable	(21.5)	4.0
Accrued expenses	(142.0)	(78.6)
Income tax	(40.0)	3.3
Deferred revenue	151.8	162.9
Other liabilities	9.7	16.2
Net cash provided by operating activities	119.5	188.0
Investing activities:
Capital expenditures on property and equipment	(78.0)	(63.2)
Payments to acquire cost- and equity-method investments	(3.6)	(5.1)
Proceeds from sale of assets	466.2	0.0
Change in other assets	(0.1)	(1.9)
Settlements of forward contracts	2.5	1.4
Net cash provided by (used in) investing activities	387.0	(68.8)
Financing activities:
Proceeds from borrowings	293.8	307.0
Repayment of borrowings	(209.1)	(392.9)
Proceeds from noncontrolling interests	0.0	12.5
Contingent consideration payments	0.0	(2.2)
Dividends paid	(67.7)	0.0
Proceeds from the exercise of employee stock options	130.9	25.7
Payments related to tax withholding for stock-based compensation	(110.0)	(62.0)
Repurchases of common shares	(500.0)	0.0
Net cash used in financing activities	(462.1)	(111.9)
Foreign exchange impact on cash balance	(12.0)	5.9
Net increase in cash and cash equivalents	32.4	13.2
Cash and cash equivalents at the end of the period	$ 143.9	$ 133.2